title: Dopamine D2 receptor brain imaging in the neonatal period using 123I-IBZM SPECT.
authors.forename: F
authors.initials: F
authors.lastname: Tranquart
authors.forename: E
authors.initials: E
authors.lastname: Saliba
authors.forename: L
authors.initials: L
authors.lastname: Zimmer
authors.forename: L
authors.initials: L
authors.lastname: Barantin
authors.forename: M
authors.initials: M
authors.lastname: Lanneau
authors.forename: D
authors.initials: D
authors.lastname: Guilloteau
authors.forename: J L
authors.initials: JL
authors.lastname: Baulieu
mesh_terms: D001549:Benzamides; D001921:Brain / Q000000981:diagnostic imaging* / Q000378:metabolism; D006801:Humans; D020925:Hypoxia-Ischemia, Brain / Q000000981:diagnostic imaging*; D007231:Infant, Newborn; D007457:Iodine Radioisotopes; D011759:Pyrrolidines; D019275:Radiopharmaceuticals; D017448:Receptors, Dopamine D2 / Q000032:analysis*; D015899:Tomography, Emission-Computed, Single-Photon
chemical_list: D001549:Benzamides; D007457:Iodine Radioisotopes; D011759:Pyrrolidines; D019275:Radiopharmaceuticals; D017448:Receptors, Dopamine D2; C055743:3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide